Health ❯Healthcare
Molecular Biology Cancer Neurodegenerative Diseases Drug Development Medical Research Cell Biology Oncology Neurodegenerative Diseases Cancer Biology Cancer Statistics
A NYU Langone Health study uncovered a reliance on EGFR signaling in NF1-mutant tumors prompting early-phase trials of cetuximab plus afatinib.